Milrinone
- Generic Name
- Milrinone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H9N3O
- CAS Number
- 78415-72-2
- Unique Ingredient Identifier
- JU9YAX04C7
- Background
Heart failure is a multifactorial condition that affects roughly 1-2% of the adult population. Often the result of long-term myocardial ischemia, cardiomyopathy, or other cardiac insults, heart failure results from an inability of the heart to perfuse peripheral tissues with sufficient oxygen and metabolites, resulting in complex systemic pathologies. Heart ...
- Indication
Milrinone is indicated for the short-term (48 hours or less) treatment of patients with acute decompensated heart failure. Milrinone administration should occur together with close monitoring using appropriate electrocardiographic equipment and should occur in a facility equipped for the immediate treatment of potential cardiac events, including ventricular ...
- Associated Conditions
- Acute Decompensated Heart Failure (ADHF), Congestive Heart Failure (CHF)
- Associated Therapies
- -
Evaluating Precision of Therapy - Milrinone
- First Posted Date
- 2013-04-26
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- The Hospital for Sick Children
- Target Recruit Count
- 52
- Registration Number
- NCT01841177
- Locations
- 🇨🇦
Hospital for Sick Children, Toronto, Ontario, Canada
🇨🇦The Hospital for Sick Children, Toronto, Ontario, Canada
Two Inodilators Postsurgery in Neonates
- First Posted Date
- 2012-04-12
- Last Posted Date
- 2012-04-12
- Target Recruit Count
- 20
- Registration Number
- NCT01576094
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Milrinone During Living Donor Hepatectomy
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2009-08-27
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 38
- Registration Number
- NCT00966745
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Milrinone Inhaled in Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2009-01-09
- Last Posted Date
- 2013-10-25
- Lead Sponsor
- Andre Denault
- Target Recruit Count
- 124
- Registration Number
- NCT00819377
- Locations
- 🇨🇦
Montreal Heart Institute, Montreal, Quebec, Canada
Levosimendan in Congenital Cardiac Surgery
- Conditions
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2010-01-26
- Target Recruit Count
- 50
- Registration Number
- NCT00695929
- Locations
- 🇧🇪
Cliniques Universitaires Saint Luc, Brussels, Belgium
Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants
- First Posted Date
- 2007-10-25
- Last Posted Date
- 2007-10-25
- Lead Sponsor
- Ludwig Boltzmann Gesellschaft
- Target Recruit Count
- 40
- Registration Number
- NCT00549107
- Locations
- 🇦🇹
Children´s Heart Center Linz, Linz, Austria
Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery
- Conditions
- Interventions
- First Posted Date
- 2007-10-12
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- John M Costello
- Target Recruit Count
- 106
- Registration Number
- NCT00543309
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG
- Conditions
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- University of Luebeck
- Target Recruit Count
- 60
- Registration Number
- NCT00446017
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.